Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models.
Kengne AP, Beulens JW, Peelen LM, Moons KG, van der Schouw YT, Schulze MB, Spijkerman AM, Griffin SJ, Grobbee DE, Palla L, Tormo MJ, Arriola L, Barengo NC, Barricarte A, Boeing H, Bonet C, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Huerta JM, Kaaks R, Key TJ, Khaw KT, Li K, Mühlenbruch K, Nilsson PM, Overvad K, Overvad TF, Palli D, Panico S, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sánchez MJ, Slimani N, Tagliabue G, Tjønneland A, Tumino R, van der A DL, Forouhi NG, Sharp SJ, Langenberg C, Riboli E, Wareham NJ.
Kengne AP, et al. Among authors: panico s.
Lancet Diabetes Endocrinol. 2014 Jan;2(1):19-29. doi: 10.1016/S2213-8587(13)70103-7. Epub 2013 Oct 8.
Lancet Diabetes Endocrinol. 2014.
PMID: 24622666
Free article.